Rapamycin News: A Roadmap to FDA Approval for Longevity Drugs
On May 27, 2026, the Reagan-Udall Foundation for the FDA, working alongside ARPA-H and the XPRIZE Foundation, ran a full-day public meeting on gerotherapeutic drug and biologic development.